Late attention has been drawn to proton therapy as a possible form of radiotherapy for the treatment of pediatric cancer. The exposure of healthy proton therapy tissue can be decreased to a minimum for infants, thereby reducing the adverse effects of radiation on the healthy tissue. Proton therapy also reduced the risk of secondary cancer because of the irradiation of smaller amounts of normal tissue. For example, in Mirabell et al., the incidence of secondary cancer with the use of proton therapy in the cerebrospinal region is projected to be reduced to 15 fold. These findings encouraged policymakers to encourage pediatric cancer proton therapy. According to Renub Research Japan Proton Therapy Market is forecasted to exceed US$ 6 Billion by 2025.
Technological advances in the market of proton therapy have culminated in the development of PBS (Pencil Beam Scanning), an innovative way to deliver the proton beam. PBS tends to achieve higher target adherence levels and applies lower dose levels to the surrounding tissues relative to other therapies. Using advanced imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), researcher can quickly identify and detect tumors deep inside the body.
Such advances in technology have made proton therapy an effective method of cancer treatment by allowing clinicians to identify the tumor position, shape, and volume accurately. Manufacturers of proton therapy devices also reduce the equipment size and sell smaller proton therapy systems at low cost. Therefore, technological advances were described as a key trend in the forecast period that will drive market growth in proton therapy.
About Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions.
Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email : info@renub.com
Web: www.renub.com
0 Comments
I you have any point please Contect Us